Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib

PDA Journal of Pharmaceutical Science and Technology

Volumn 61, Issue 2, 2007, Pages 88-96

  Ali, Javed ^a   Tyagi, Puneet ^a   Ahuja, Alka ^a   Baboota, Sanjula ^a   Hasan, Sohail ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Celecoxib; Eudragit S; Gastroretentrive microspheres; Polyethylene oxide

Indexed keywords

ALCOHOL; CELECOXIB; CELIB; CELLULOSE ACETATE; DICHLOROMETHANE; DODECYL SULFATE SODIUM; EUDRAGIT; MACROGOL; MICROSPHERE; POLYMER; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; EMULSION; IN VITRO STUDY; SCANNING ELECTRON MICROSCOPY; SIMULATION; STOMACH ABSORPTION; STOMACH JUICE; STOMACH PH; X RAY DIFFRACTION;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CYCLOOXYGENASE INHIBITORS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; ETHANOL; GASTRIC JUICE; HYDROGEN-ION CONCENTRATION; KINETICS; METHYLENE CHLORIDE; MICROSPHERES; MODELS, CHEMICAL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; POLYMETHACRYLIC ACIDS; POROSITY; PYRAZOLES; SOLUBILITY; SOLVENTS; STOMACH; SULFONAMIDES; TECHNOLOGY, PHARMACEUTICAL;

EID: 34247480864     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Singh, B. N.; Kim, K. H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Controlled Release 2000, 63 (3), 235-259.
2. Soppimath, K. S.; Kulkarni, A. R.; Rudzinski, W. E.; Tejraj, M. A. Microspheres as floating delivery systems to increase the gastric residence of drugs. Drug Metab. Rev. 2001, 33, 149-160.
3. Joseph, N. J.; Lakshmi, S.; Jayakrishanan, A. Floating type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J. Controlled Release 2002, 79 (1-3), 71-79.
4. Arora, S.; Ali, J.; Ahuja, A.; Khar, R. K.; Baboota, S. Floating drug delivery systems: an updated review. AAPS PharmSciTech 2005, 6 (3), E372-E390.
5. Paulson, S. K.; Vaughn, M. B.; Jessen, S. M.; Lawal, Y.; Gresk, C. J.; Yan, B.; Maziasz, J.; Cook, C. S.; Karim, A. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J. Pharmacol. Exp. Ther. 2001, 297 (2), 638-645.
6. Kawashima, Y.; Niwa, T.; Takeuchi, H.; Hino T.; Ito, T. Preparation of multiple unit hollow microspheres with acrylic resins containing transilat and their drug release characteristics (in vitro) and floating behaviour (in vivo). J. Controlled Release 1991, 16, 279.
7. Ali, J.; Hasan, S.; Ali, M. Formulation and development of gastroretentive drug delivery system for ofloxacin. Methods Find. Exp. Clin. Pharmacol. 2006, 28 (7), 433-439.
8. Rasalkar, S. Development and Evaluation of a Hydrodynamically Balanced System of Nifedipine for Once Daily Oral Administration. M Pharm Dissertation, Jamia Hamdard, New Delhi, 1994.
9. El-Kamel, H.; Sokar, M. S.; Al Gamal, S. S.; Naggar, V. F. Preparation and evaluation of ketoprofen floating oral delivery system. Int. J. Pharm. 2001, 220 (1-2), 13-21.
10. Dhabu, P. M.; Akamanachi, K. G. A stability-indicating HPLC method to determine celecoxib in capsule formulations. Drug Dev. Ind. Pharm. 2002, 28 (7), 815-821.